Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
Paller CJ, Barata PC, Lorentz J, Appleman LJ, Armstrong AJ, DeMarco TA, Dreicer R, Elrod JAB, Fleming M, George C, Heath EI, Hussain MHA, Mao S, McKay RR, Morgans AK, Orton M, Pili R, Riedel E, Saraiya B, Sigmond J, Sokolova A, Stadler WM, Tran C, Macario N, Vinson J, Green R, Cheng HH; PROMISE Trial Investigators. Paller CJ, et al. Among authors: lorentz j. Prostate. 2024 Feb;84(3):292-302. doi: 10.1002/pros.24650. Epub 2023 Nov 14. Prostate. 2024. PMID: 37964482
Treatment Outcomes in Male Breast Cancer: A Retrospective Analysis of 161 Patients.
Wan BA, Ganesh V, Zhang L, Sousa P, Drost L, Lorentz J, Vesprini D, Lee J, Rakovitch E, Lu FI, Eisen A, Yee C, Lam H, Chow E. Wan BA, et al. Among authors: lorentz j. Clin Oncol (R Coll Radiol). 2018 Jun;30(6):354-365. doi: 10.1016/j.clon.2018.02.026. Epub 2018 Mar 2. Clin Oncol (R Coll Radiol). 2018. PMID: 29496323
The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreat.
Clark R, Kenk M, McAlpine K, Thain E, Farncombe KM, Pritchard CC, Nussbaum R, Wyatt AW, de Bono J, Vesprini D, Bombard Y, Lorentz J, Narod S, Kim R, Fleshner N. Clark R, et al. Among authors: lorentz j. Can Urol Assoc J. 2021 Dec;15(12):E623-E629. doi: 10.5489/cuaj.7383. Can Urol Assoc J. 2021. PMID: 34171218 Free PMC article.
Response to: The Survival Time of 8376 Male Breast Cancer Patients.
Wan BA, Ganesh V, Zhang L, Sousa P, Drost L, Lorentz J, Vesprini D, Lee J, Rakovitch E, Lu FI, Eisen A, Yee C, Lam H, Chow E. Wan BA, et al. Among authors: lorentz j. Clin Oncol (R Coll Radiol). 2018 Dec;30(12):818-819. doi: 10.1016/j.clon.2018.08.011. Epub 2018 Sep 10. Clin Oncol (R Coll Radiol). 2018. PMID: 30213703 No abstract available.
An appraisal of genetic testing for prostate cancer susceptibility.
Finch A, Clark R, Vesprini D, Lorentz J, Kim RH, Thain E, Fleshner N, Akbari MR, Cybulski C, Narod SA. Finch A, et al. Among authors: lorentz j. NPJ Precis Oncol. 2022 Jun 22;6(1):43. doi: 10.1038/s41698-022-00282-8. NPJ Precis Oncol. 2022. PMID: 35732815 Free PMC article. Review.
30 results